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The interaction between host and pathogen decidedly shapes the outcome of an infec-
tion, thus understanding this interaction is critical to the treatment of a pathogen-induced 
infection. Although research in this area of cell biology has yielded surprising findings 
regarding interactions between host and pathogen, understanding of the metabolic 
cross talk between host and pathogen is limited. At the site of infection, host and 
pathogen share similar or identical nutritional substrates and generate common meta-
bolic products, thus metabolic cross talk between host and pathogen could profoundly 
affect the pathogenesis of an infection. In this review, we present results of a recent 
discovery of a metabolic interaction between host and pathogen from an amino acid 
(AA) metabolism-centric point of view. The host depends on AA metabolism to support 
defensive responses against pathogens, while the pathogens modulate AA metabolism 
for its own advantage. Some AA, such as arginine, asparagine, and tryptophan, are 
central points of competition between the host and pathogen. Thus, a better under-
standing of AA-mediated metabolic cross talk between host and pathogen will provide 
insight into fruitful therapeutic approaches to manipulate and prevent progression of 
an infection.
Keywords: amino acids, arginine, asparagine, metabolism, infection
Abbreviations: AA, amino acids; ADI, arginine deiminase; ADR, arginine deprivation response; AhR, aryl hydrocarbon recep-
tor; ALR, AIM2 (absent in melanoma 2)-like receptor; AnsA, asparaginase; AnsP2, asparagine transporter; AP-1, activator 
protein-1; ATF, activating transcription factor; CAT, cationic amino acid transporter family; CLRs, C-type lectin receptors; 
DCs, dendritic cells; EHEC, enterohaemorrhagic Escherichia coli; ETEC, enterotoxigenic Escherichia coli; GABA, gamma-
aminobutyric acid; GAS, group A Streptococcus; GCN2, general control nonderepressible 2; GDAR, glutamate-dependent acid 
resistance; HBV, hepatitis B virus; HCMV, human cytomegalovirus; IDO, indoleamine 2,3-dioxygenase; iNOS, inducible nitric 
oxide synthase; IL, interleukin; MAPK, mitogen-activated protein kinase; MPK2, mitogen-activated protein kinase 2; mTORC1, 
mechanistic target of rapamycin complex 1; NF-κB, nuclear factor-κB; NLRs, nucleotide-binding oligomerization domain-like 
receptors; NO, nitric oxide; NOS, NO synthase; PAMPs, pathogen-associated molecular patterns; PCV2, porcine circovirus 
type 2; PERK, protein kinase-like endoplasmic reticulum kinase; PRRs, pathogen recognition receptors; ROS, reactive oxygen 
species; RLRs, retinoic acid-inducible gene-I-like receptors; SCV, Salmonella-containing vacuole; SNAT2, sodium-dependent 
neutral amino acid transporter 2; STAT, signal transducer and activator of transcription; TLRs, toll-like receptors.
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iNTeRACTiON BeTweeN HOST AND 
PATHOGeN
The interaction between host and pathogen has a profound effect 
on the outcome of an infection. The host senses the presence 
of the pathogen through recognition of pathogen-associated 
molecular patterns, which are highly conserved. Cells of the 
host recognize unique molecules present on pathogens via 
pathogen recognition receptors, including toll-like receptors 
(TLR), C-type lectin receptors, nucleotide-binding oligomeriza-
tion domain-like receptors, retinoic acid-inducible gene-I-like 
receptors, and AIM2 (absent in melanoma 2)-like receptor 
(ALR) (1, 2). Pathogen recognition by immune cells of the host 
results in activation of a common set of cell signaling pathways, 
including nuclear factor-κB (NF-κB), activator protein-1, and 
mitogen-activated protein kinase (MAPK). These signaling 
pathways modulate the immune responses of the host against 
the pathogen that include production of proinflammatory 
cytokines/chemokines, migration of neutrophils, and secretion 
of antibodies (1–3). However, the pathogen is usually equipped to 
evoke countermeasures to inhibit the host’s immune responses. 
For example, pathogenic Escherichia coli inhibit the activation 
of NF-κB through its pathogenicity factors, such as NleH1 and 
NleB (4–6).
Knowledge about host–pathogen interactions is obviously 
critical for understanding the pathogenesis of infection; how-
ever, it generally overshadows knowledge of metabolic cross talk 
between host and pathogen. At the site of infection, which can 
be regarded as a closed system, host and pathogen share similar 
nutritional substrates and generate common metabolic products. 
The host depends upon nutritional substrates to support its 
immune responses against the pathogen, while the pathogen is 
also highly dependent on nutritional substrates for its physiol-
ogy because most pathogens are unable to synthesize some 
nutritional substrates. For example, Plasmodium falciparum has 
completely lost its capacity for de novo biosynthesis of amino 
acids (AA), thus it depends primarily on AA scavenging from the 
host and through the catabolism of hemoglobin (7, 8). Usually, 
the host experiences significant metabolic alterations after the 
infection by a pathogen (9–11), and a slight change in metabo-
lism at the site of infection will remarkably shape the outcome 
of an infection. For example, the host experiences a significant 
change in glucose metabolism to support immune responses 
against pathogens, such as activation of T cells and monocytes, 
activation of inflammasome signaling, and production of IL-1 
β (12–14). The abundances of glucose and α-glucan in the host 
affect global gene expression of Streptococcus suis, including the 
virulence factor amylopullulanase, which promotes epithelial 
cell adherence (15). Fucose from the host’s intestinal microbiota 
affects the metabolism of enterohaemorrhagic Escherichia coli 
and its expression of virulence genes for intestinal colonization 
(16). In essence, the host modulates the availability of nutritional 
substrates or metabolic products to effect the progression of 
pathogen-induced infection, while the pathogen uses the same 
or similar substrates to sense the anatomical location and the 
physiological status of the host to adapt (17). For example, the 
host achieves a metal-limited environment during infection by 
expressing calprotectin which chelates manganese; however, 
Acinetobacter baumannii coordinates transcription of a man-
ganese transporter to facilitate manganese accumulation and 
overcome the manganese limitation resulting from expression 
of calprotectin (18). Indeed, there is fierce competition for 
trace elements and metabolic precursors between pathogen and 
host. Therefore, the host experiences a significant alteration in 
metabolism during infection, including metabolism of glucose, 
fatty acid, and AA (19–21). Evidence for metabolic cross talk 
between a pathogen and its host was highlighted in a recent 
review by Olive and Sassetti (17); however, a number of key 
areas involving AA interactions between pathogen and its host 
require further in-depth research. In this review, we examine 
metabolic interactions between host and pathogen from an AA 
metabolism-centric point of view.
AA AFFeCTS THe iMMUNe SYSTeM 
OF THe HOST
Numerous reviews indicate that AA metabolism shapes the host’s 
physiology, including growth, reproduction, and immunity. 
AA metabolism affects the physiology of the host by serving as 
an energy source for cells (e.g., lymphocytes, fibroblasts, and 
enterocytes), a basic substrate for protein synthesis, a substrate 
for production of regulatory molecules [e.g., nitric oxide (NO), 
polyamines, and creatine], a regulator for cell signaling pathways 
[e.g., mechanistic target of rapamycin complex 1 (mTORC1), 
MAPK, and NF-κB], and a regulator for host metabolism and 
intestinal microbiota (22, 23). Recent compelling results indi-
cate that AA have a significant influence on immune responses 
of the host. For example, arginine or glutamine effect activation 
of the innate immune system, such as TLR signaling, secretory 
immunoglobulin A (SIgA), and Paneth antimicrobials, as well as 
activation of intestinal cell signaling pathways, such as NF-κB, 
MAPK, and PI3K–Akt (24–26). Indeed, glutamine promotes 
intestinal secretion of SIgA through the intestinal microbiota, 
and involving both T  cell-dependent and T  cell-independent 
pathways (27). These investigations revealed that AA influence 
the innate immunity of the host; however, the importance of AA 
in adaptive immunity during infection is not known. AA [e.g., 
leucine, glutamine, and gamma-aminobutyric acid (GABA)] 
are of critical importance in mediating T cell function, includ-
ing activation and differentiation of T cells, especially for Th1 
and Th17 cells (20, 28, 29). For example, extracellular serine is 
required for optimal T cell expansion even though the concen-
tration of glucose is sufficient to support activation, bioenerget-
ics, and effector functions of T cells (30). Mechanistically, the 
influence of AA on the immune system of the host may largely 
depend on mTORC1 signaling since AA-induced mTORC1 
signaling is required for differentiation of Th17 cells and their 
expression of IL-17 (20). Collectively, available results indicate 
that AA are of critical importance for shaping the immune 
functions of the host, including innate immunity and adaptive 
immunity.
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AA eFFeCT GROwTH AND eXPReSSiON 
OF viRULeNCe FACTORS BY 
PATHOGeNS
A pathogen requires AA to support its physiological functions, 
and alterations in AA availability have remarkable effects on 
growth of a pathogen and its expression of virulence factors. 
For example, the addition of asparagine to Dulbecco’s Modified 
Eagle Medium promotes activation of the streptococcal invasion 
locus (sil) in Group A Streptococcus (GAS) (31). Dietary con-
tent of glutamine significantly affects the burden of Pasteurella 
multocida and the expression of its virulence factors (32). 
A high content of glutamine increases the bacterial burden in 
all tissues analyzed, including the heart, liver, spleen, lung, and 
kidney (32). Glutamine promotes the expression of virulence 
factors in the lung, including ompA, pm0442, pm0979, plpE, 
and hasR, and expression of pm0442, plpE, and hasR in the 
spleen (32). Similarly, glutamine acts as an on/off switch for 
the induction of virulence genes of Listeria monocytogenes 
(33). There is no virulence gene transcription by L. monocy-
togenes when concentrations of glutamine in macrophages are 
below the threshold, while there is maximum transcription 
of virulence genes when concentrations of glutamine exceed 
threshold concentrations of glutamine (33). Inactivation of 
GlnPQ (a l-glutamine high affinity ABC transporter) results 
in complete arrest of glutamine uptake, a dramatic reduction 
in expression of virulence genes, and attenuated virulence in a 
mouse infection model (33). These results indicate the impor-
tance of AA, especially glutamine, in the growth of a pathogen 
and its expression of virulence factors. AA metabolism is also 
of critical importance for pathogens to overcome defensive 
responses of the host. For example, the host imposes manganese 
and zinc starvation during Staphylococcus aureus infection, 
impairing glycolysis in S. aureus because manganese and zinc 
are essential for the activitiy of certain glycolytic enzymes in 
S. aureus (34). Glucose and other sugars are the preferred 
carbon source utilized by S. aureus to generate energy, and 
impaired glycolysis decreases the growth of S. aureus (34, 35). 
However, S. aureus overcomes this deficiency by shifting away 
from metabolism of sugars as an energy source to the metabo-
lism of AA for energy and to reduce demand for manganese 
and zinc (34). Collectively, AA significantly affect the growth of 
pathogens and their expression of virulence factors.
Assimilation of local nutrients is also essential for fungal 
pathogens to establish an infection in their mammalian host. 
AA metabolism is crucial to the pathogenicity of major fungal 
pathogens such as Candida albicans. Metabolic adaptation to the 
microenvironments of the host is associated with fungal mor-
phogenesis, cell wall remodeling, biofilm formation and stress 
responses, commensalism, all of which influence progression of 
infections. Metabolic adaptation is regulated by complex tran-
scriptional networks such as the general control of AA metabo-
lism (GCN response) in fungal species such as Saccharomyces 
and Candida (36). The exposure of C. albicans to macrophages 
or neutrophils induces expression of a cluster of genes required 
for nutrient assimilation and AA metabolism, as well as genes 
associated with hyphal growth (ECE1), adhesion (HWP1), 
and adaptation to oxidative stress (SOD1 and CAT-1) (37–39). 
Candida glabrata also increases the biosynthesis of both arginine 
and lysine in response to their internalization by macrophages 
(40). AA catabolism stimulates hyphal morphogenesis in C. albi-
cans (41). Moreover, our recent transcriptomic analyses revealed 
the critical role of metabolism of AA, such as arginine, proline, 
aspartate, and glutamate metabolism, on biofilm formation by 
C. albicans (42). The aspartate aminotransferase gene is a common 
member of these AA pathways and it is significantly upregulated 
in isolates have a high capacity for producing biofilm (42).
During host tissue damage and invasion, C. albicans secretes 
various aspartic proteases, which liberate AA from host proteins 
(43). Released AA form peptides that are then taken up by 
C. albicans via dedicated oligopeptide transporters (Opt1–8) and 
other membrane AA permeases (44). Moreover, during a glucose 
deficiency C. albicans exploits AA as a carbon source, excreting 
excess nitrogen in the form of ammonia, potentially altering 
the pH of the host environment, and thereby triggering hyphal 
development (41). This process can contribute to neutraliza-
tion of the acidic environment in phagosomes of macrophages 
(45, 46). In Cryptococcus neoformans upregulation of expression 
of AA transporters is a survival mechanism within macrophages 
(47). Overall, in fungal species, there is tight coordination of 
nutrient sensing and metabolic pathways via transcriptional 
circuitry, which regulates the global activation of AA biosynthesis 
in response to the dynamic nature of local niches of infection.
AA MeTABOLiC ALTeRATiON AFTeR 
iNFeCTiONS
There are significant metabolic alterations in AA at the site 
of infection or even other anatomic sites during an infection. 
For example, a C. neoformans infection perturbs the content 
of cysteine in the human lung epithelial cell line (A549) after 
6  h (48). Plasmodium yoelii infection alters concentrations of 
AA in plasma of infected mice, including increases in 10 AA 
(valine, leucine, tyrosine, phenylalanine, EOHNH2, histidine, 
proline, aspartate, glutamate, alanine) and decreases in five AA 
(citrulline, cysteine, methionine, 1-MeHis, and arginine) (49). 
P. yoelii infection also increases 21 AA in the liver of mice, 
including threonine, asparagine, and arginine (49). Similarly, 
P. yoelii infection affects the abundance of AA in red blood cells 
(8). Using NMR (nuclear magnetic resonance)-based metabo-
lomics to study white spot syndrome virus infection in crayfish 
gills, the virus: (1) increases glutamate, alanine, and methionine 
at 1 h postinfection; (2) increases alanine, tryptophan, histidine, 
tyrosine, and methionine at 6 h postinfection; and (3) increases 
the abundances of alanine, valine, leucine, isoleucine, glutamate, 
glutamine, phenylalanine, tyrosine, threonine, and methionine at 
6 h postinfection in crayfish hepatopancreas (50). Enterotoxigenic 
Escherichia coli (ETEC) infection reduces concentrations of 
isoleucine in the serum of piglets (9). In the jejunum, the abun-
dances of six AA changes after an ETEC infection, which includes 
decreases in the abundances of glutamine, asparagine, citrulline, 
and ornithine, and increases in the abundances of glycine and 
FiGURe 1 | Extensive amino acid (AA) metabolism and communication 
between the host and Salmonella or Shigella. Salmonella (A, 1–2 h 
postinfection) or Shigella infection induces a rapid state of AA starvation 
through aseptic membrane damage (AMD), which inhibits the activation of 
mechanistic target of rapamycin complex 1 (mTORC1). mTORC1 negatively 
controls the autophagy response, which is responsible for targeting and 
degradating Salmonella or Shigella. However, Salmonella escapes from the 
autophagy-mediated degradation through replenishment of intracellular AA 
pools to reactivate mTORC1 signaling at a later phase of the infection (B).
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GABA (51). Changes in concentrations of AA in serum of mice 
infected with porcine circovirus type 2 (PCV2) have been studied 
systematically using isotope dilution liquid chromatography 
(LC)-mass spectrometry methods (52). PCV2 infection increases 
concentrations of proline, ornithine, and methionine in serum on 
day 3 postinfection, while concentrations of aspartate, arginine, 
proline, lysine, valine, isoleucine, and leucine decreases on day 
7 postinfection, and there is no effect of PCV2 infection on con-
centrations of AA in serum on either day 10 or 14 postinfection 
(52). Those results indicate significant changes in concentrations 
of AA in serum of the host, but the exact mechanism for the 
changes is not known. However, changes in concentrations of AA 
in serum after PCV2 infection may result from changes in either 
AA metabolism or AA transport. Among seven AA transporters 
(i.e., Slc6a14, Slc6a20, Slc7a5, Slc7a6, Slc7a7, Slc7a8, and Slc7a9) 
responsible for the transport of these altered AA, PCV2 infection 
decreases the expression of Slc7a5 and Slc7a6 in the jejunum on 
day 7 postinfection (52).
AA AS MeDiATORS OF MeTABOLiC 
CROSS TALK BeTweeN HOST AND 
PATHOGeN
A compelling example of extensive AA-dependent metabo lic 
communication between host and pathogen occurs during 
infec tion with Salmonella or Shigella (Figure  1). Those infec-
tions rapidly induce a state of AA starvation in epithelial cells, 
which reduces abundances of leucine/isoleucine in cytosol, and 
inhibits activation of mTORC1, but induces the general control 
nonderepressible 2-dependent stress response pathway to 
promote expression of activating transcription factor 3 (ATF3) 
(53) (Figure  1). This starvation is induced through aseptic 
membrane damage, but not protein metabolism because chlo-
ramphenicol has little effect on the expression of ATF3 while 
inhibiting synthesis of bacterial proteins (53). AA starvation 
may inhibit the host’s innate immune responses and adaptive 
immune responses against pathogens, but activate host cell 
autophagy responses which are normally inhibited by mTORC1 
(54) (Figure 1). Autophagy is a highly conserved cellular process 
that triggers nutrient recycling to sustain essential metabolic 
functions during nutrient or energy deprivation (55). Autophagy 
involves degradation and recycling of cellular constituents, such 
as dysfunctional organelles or macromolecular complexes (55). 
Autophagy also promotes targeting and degradation of intracel-
lular bacteria (53, 56, 57), such as Shigella or Salmonella, and 
has important roles in the pathogenesis of extracellular bacterial 
infections, such as ETEC (58, 59). However, Salmonella could 
escape from autophagy-mediated degradation through the 
replenishment of intracellular AA pools to recruit and reactivate 
mTORC1 signaling at the surface of the Salmonella-containing 
vacuole (SCV) (53) (Figure 1).
A small change in cell and tissue content of AA after an infec-
tion has substantial effects on the ultimate outcome of the infec-
tion, and both host and pathogen can influence the availability 
of AA (e.g., asparagine, arginine, and tryptophan) and amounts 
of their metabolic products (e.g., NO, polyamines, kynurenine) 
at the site of infection to their respective advantages. The discus-
sion will now focus on a few specific AA, arginine, asparagine, 
and tryptophan, which affect competition between host and 
pathogen, and strategies used by the pathogen to compete with 
the host for these AA, although the pathogen may also compete 
with the host for other AA.
Arginine
Utilization of arginine by both host and pathogen represents 
a metabolic bottleneck which is critical in determining the 
outcome of a pathogenic infection (17). The two predominant 
pathways for arginine metabolism are via NO synthase (NOS) 
for NO production and via arginase and ornithine decarboxy-
lase for production of polyamines (putrescine, spermidine, and 
spermine). NO is an antimicrobial molecule, while polyamines 
are essential for the proliferation of pathogens (e.g., Leishmania). 
During infection, macrophages increase expression of inducible 
nitric oxide synthase (iNOS) to produce NO from arginine for 
antimicrobial purposes (60). However, the activity of iNOS in 
macrophages is highly dependent on the abundance of arginine 
in host cells (e.g., macrophages) and this influences the fate of 
an infection (61, 62). Arginase competes with iNOS for arginine; 
therefore, many pathogens exploit this to block NO production 
by increasing expression of arginase to limit arginine availability 
for metabolism via iNOS (61–63). One compelling example of the 
extensive competition for arginine between a host and a patho-
gen occurs during infections with Leishmania (Figure 2). Upon 
Leishmania invasion, infected macrophages activate cytotoxic 
pathways in an attempt to kill the pathogen, including the induc-
tion of NO biosynthesis from arginine; however, Leishmania 
infection upregulates arginase I activity in macrophages, thereby 
decreasing the availability of arginine for metabolism via iNOS 
(Figure 2) (64, 65). Mechanistically, the increase in Th2 cytokines 
FiGURe 2 | Competition between the host and Leishmania or Streptococcus pyogenes for arginine. (A) After Leishmania invasion, the infected macrophage 
produces nitric oxide (NO) from arginine via NO synthase (NOS) to kill Leishmania while Leishmania uses macrophage arginase I (a) to limit the amount of arginine 
available for synthesis of NO via NOS by macrophages. Mechanistically, the increase in Th2 cytokines during Leishmania infection, such as interleukin (IL)-4 and 
IL-5, induces the expression of arginase I in macrophages to produce polyamines. Leishmania directly activates signal transducer and activator of transcription-6 
(STAT6) to increase the expression of arginase I in macrophages. Leishmania also uses the arginine transporter (amino acid permease 3, AAP3) (b) to compete with 
macrophages for arginine. During macrophage invasion by Leishmania, there is a coordinated arginine deprivation response mediated via the mitogen-activated 
protein kinase 2 (MPK2) cell signaling pathway, which upregulates arginine transport away from the macrophage. Leishmania uses polyamines to produce 
trypanothione that neutralizes effects of reactive oxygen species (ROS) released from macrophages. (B) Streptococcus pyogenes uses the arginine deiminase (ADI) 
pathway to limit available arginine for NO production by macrophages. This pathway includes the ArcD antiporter, which concomitantly transports ornithine out and 
arginine into the cell, enzymes which convert arginine to ornithine, CO2, NH3, and one molecule of adenosine triphosphate (ATP). The NH3 can be utilized to buffer 
against acid stress.
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during Leishmania infection, such as IL-4, IL-10, and transform-
ing growth factor-beta, induces the expression of macrophage 
arginase I (64), or Leishmania directly activates signal transducer 
and activator of transcription-6 to promote expression of arginase 
I (66). Although pathogenic Leishmania (L. major and L. tropica) 
induces increases in arginase activity in susceptible BALB/c 
mice, and even in resistant C57BL/6 mice, there is no change in 
arginase activity at the site of infection and in the draining lymph 
nodes of either strain of mice during non-pathogenic Leishmania 
(L. tarentolae) infection (67).
Arginase in Leishmania can also subvert antimicrobial 
activity of macrophages by diverting arginine away from iNOS. 
Leishmania lacking arginase have poorer survival in mouse mac-
rophages, and the decrease in intracellular survival is abrogated 
in iNOS-deficient macrophages (68). l-ornithine, the product 
of arginase, is used for the production of polyamines required 
for growth of Leishmania (64). In addition, Leishmania uses 
spermidine to produce trypanothione which neutralizes reactive 
oxygen species (ROS) released by macrophages (69) (Figure 2). 
Interestingly, an a comparison of arginase genes in patho ge-
nic Leishmania (L. major and L. tropica) and non-pathogenic 
Leishmania (L. tarentolae) revealed that amino acid sequences 
of arginase from the pathogenic and non-pathogenic Leishmania 
are 98.6 and 88% identical to the reference gene in L. major 
Friedlin, respectively, and that the activity of arginase is greater 
in pathogenic than non-pathogenic Leishmania (67). Leishmania, 
P. falciparum infection also causes a rapid depletion of arginine 
through activation of arginase (8). Patients with P. falciparum 
infection have lower concentrations of l-arginine in their plasma 
and exhale less NO than controls, while l-arginine infusion 
increases concentrations of l-arginine in their plasma, exhaled 
NO, and other clinical indices without important side effects in 
P. falciparum-infected patients with malaria (70). Thus, a patho-
gen may affect the activity of arginase in the host and, therefore, 
arginine availability to cells of the infected host.
Leishmania also competes with macrophage for arginine 
by depleting arginine from phagolysosomes via changes in an 
arginine transporter (amino acid permease 3, AAP3) (Figure 2) 
(71). During macrophage invasion, there is a coordinated 
arginine deprivation response induced in Leishmania through 
a mitogen-activated protein kinase 2-mediated signaling path-
way which upregulates expression of arginine transporters in 
Leishmania and arginine transport from the macrophage reduces 
available arginine for synthesis of NO via NOS by macrophages 
(71). Salmonella infection promotes the expression of arginine 
transporters in macrophages, including the cationic amino 
acid transporter members (CAT)-1 and 4 (61, 62). CAT-1 is 
preferentially localized in the cell membrane of uninfected 
macrophages, while CAT-1 is localized in close proximity to SCV 
in infected macrophages, which promotes the usage of arginine 
from macrophages by Salmonella via the arginine permease 
lysine–arginine–ornithine-binding periplasmic protein ArgT 
(61, 62). Interestingly, intracellular Mycobacterium bovis BCG 
also promotes the colocalization of CAT-1 to the intracellular 
TABLe 1 | Strategies used by pathogens to compete with the host for arginine, 
asparagine, and tryptophan.
AA Strategies Representative 
pathogen
Reference
Arginine Arginase induction in host Leishmania (64, 65)
Pathogen encoded arginase 
activity
Leishmania (68)
Plasmodium falciparum (8)
Upregulation of arginine  
and other transporters
Leishmania (71)
Salmonella (61, 62)
Via arginine deiminase 
pathway
Streptococcus 
pyogenes
(74, 75)
Asparagine Asparagine synthetase 
induction in host
Group A Streptococcus (31, 76, 77)
Scavenge using  
asparagine transporter
Mycobacterium 
tuberculosis
(78)
Pathogen encoded 
asparaginase activity
Mycobacterium 
tuberculosis
(78)
Salmonella typhimurium (79–81)
Tryptophan Indoleamine 
2,3-dioxygenase  
induction in host
Clostridium difficile (82)
Mycobacterium avium 
subsp. paratuberculosis
(83)
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BCG in macrophages (61, 62). Thus, M. bovis BCG may enhance 
expression of CAT-1 and CAT-2B for uptake of arginine into 
macrophages without a significant increase in NO production by 
infected macrophages (72, 73).
Pathogens also compete with macrophages for arginine via 
the arginine deiminase (ADI) pathway. The ADI pathway is 
critically important for Streptococcus pyogenes infection because 
S. pyogenes uses this pathway to increase the production of cellular 
energy and provide protection against acidic stress (Figure 2) (74, 
75). This pathway includes the ArcD antiporter, which transports 
ornithine out and concomitantly brings arginine into the cell, 
and ArcA (ADI), ArcB (ornithine carbamoyl transferase), and 
ArcC (carbamate kinase) which convert arginine to ornithine, 
CO2, NH3, and one molecule of adenosine triphosphate (ATP) 
(75). NH3 can be utilized to buffer against acidic stress by reacting 
with protons from the fermentative metabolism of S. pyogenes 
and the accumulation of lactic acid. The ADI pathway mediates 
consumption of arginine and limits the availability of arginine 
for NO⋅ production by macrophages infected with S. pyogenes 
(Figure 2) (75).
Overall, during infection, the host uses arginine as a substrate 
to produce NO to protect itself against the pathogen, while, in 
parallel, the pathogen uses various mechanisms including argin-
ase, arginine transport and the ADI pathway to deplete arginine 
and/or divert arginine away from host cells that produce NO 
(Table 1).
Asparagine
Asparagine is an important source of nitrogen for pathogens, 
especially GAS that is an extracellular pathogen infecting the 
human throat and skin. GAS creates endoplasmic reticulum 
stress (ERS) in host cells through its streptolysin toxins which 
causes transmembrane pores on host cells to permit extracel-
lular calcium influx into the cytosol to dysregulate intracellular 
calcium (31, 84) (Figure  3). The ERS response activates the 
protein kinase-like endoplasmic reticulum kinase, which induces 
activation of transcription factor 4 and an increases expression of 
asparagine synthetase for production of asparagine (31, 76, 77) 
(Figure 3). Asparagine promotes GAS proliferation and changes 
the expression of about 17% of the GAS genes (including those 
for virulence, growth, and metabolism) partly through the two-
component system TrxSR (31) (Figure 3). Asparaginase, which 
hydrolyzes asparagine into aspartate, blocks GAS growth in 
human blood and GAS proliferation in a mouse model of human 
bacteremia (31).
Asparagine is also essential for an intracellular pathogen (e.g., 
Mycobacterium tuberculosis) to resist acidic stress in a phago-
some. Asparagine supports M. tuberculosis resistance to acidic 
stress by serving as substrate for production of the weak base 
ammonia, which reacts with protons in the phagosome to form 
ammonium ions (Figure 3) (78, 85, 86). M. tuberculosis expres-
sion of the asparagine transporter (AnsP2) increases markedly 
during infection to capture asparagine from macrophages (78). 
M. tuberculosis also expresses asparaginase (AnsA), which 
hydrolyzes asparagine into aspartate and ammonia (78). AnsA 
can also be secreted into the lumen of the phagosome of a 
macrophage through the type VII secretion system to hydrolyze 
asparagine for the production of aspartate and ammonia (78).
Besides its required role for pathogen survival and infection, 
asparagine is required for T  cell activation. For example, the 
absence of asparagine in medium abolishes T  cell activation 
induced by anti-CD3 and anti-CD28 antibodies, and also inhib-
its T cell blastogenesis and IL-2 secretion (80). Mechanistically, 
asparagine may affect T cell functions through mTORC1 which 
is critically important for T  cell activation and differentiation, 
especially for Th1 and Th17 cells (9). Thus, the pathogen could 
inhibit the immune response of the host by inducing starvation of 
asparagine in host cells. For example, Salmonella Typhimurium 
infection induces asparagine deprivation by hydrolyzing aspara-
gine via S. Typhimurium asparaginase, resulting in inhibition of 
mTOR signaling, Myc expression, T cell activation, and immune 
responses in the host (79–81). Using gas chromatography-mass 
spectrometry based metabolomics, ETEC was found to induce 
asparagine deprivation in the jejunum of piglets (51), but not 
in serum (9). This decrease may be responsible for inhibition of 
immune responses in the jejunum of piglets after ETEC infec-
tion (87). An ETEC infection inhibits activation of the NF-κB 
and MAPK pathways in the jejunum, and expression of TLR and 
other indicators associated with intestinal immunity, includ-
ing phospholipase A2, lysozyme, polymeric immunoglobulin 
receptor, and mucin 2 (87, 88). However, in response to the 
ETEC infection, piglets try to alleviate asparagine deprivation by 
upregulating asparagine synthetase in the jejunum. Those results 
are based on the use of isobaric tags for relative and absolute 
quantitation (iTRAQ) combined with multi-dimensional LC and 
MS analysis (87). Interestingly, piglets with diarrhea have a lower 
content of asparagine in the jejunum than control piglets (51), 
whereas resistant and control piglets have similar contents of 
FiGURe 3 | The role of asparagine in Mycobacterium tuberculosis and group A Streptococcus (GAS) infections. (A) Asparagine supports M. tuberculosis resistance 
to acid stress. M. tuberculosis expresses an asparagine transporter (AnsP2), which captures asparagine from macrophages, and asparaginase (AnsA), which 
hydrolyzes asparagine into aspartate and ammonia. Ammonia can react with protons in the phagosome to form ammonium ions. AnsA can also be secreted into 
the lumen of the phagosome of the macrophage through the type VII secretion system to hydrolyze asparagine to aspartate and ammonia. (B) Asparagine regulates 
GAS proliferation and expression of virulence factors. GAS infection creates endoplasmic reticulum stress (ERS) in host cells through effects of its streptolysin toxins 
on extracellular calcium signaling. ERS activates the protein kinase-like endoplasmic reticulum kinase (PERK), which induces the activation of the transcription factor 
activating transcription factor 4 (ATF4) to increase in the expression of asparagine synthetase and the production of asparagine. Asparagine promotes GAS 
proliferation and the expression of its virulence factors.
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asparagine in the jejunum, and piglets that have recovered from 
ETEC-induced diarrhea restore their asparagine content, com-
pared to piglets that did not recover from diarrhea (manuscript 
submitted).
Collectively, available results indicate that the competitive 
utilization of asparagine by pathogens via asparagine syn-
thetase, asparagine transporter, and asparaginase (Table 1) has 
important influences on the pathogenesis of infection and the 
outcome of an infection.
Tryptophan
Tryptophan is required for optimal immune responses, such as 
T  cell proliferation (Figure  4). For example, activated T  cells 
placed under tryptophan-deficient conditions undergo a mid-
G1 arrest in cell cycle progression (89, 90). The tryptophan pool 
diminishes due to its conversion into kynurenine by indoleam-
ine 2,3-dioxygenase (IDO) (Figure  4). Various regulators, 
including interferon (IFN)-α, IFN-γ, tumor necrosis factor-α, 
and prostaglandins, regulate the expression of IDO (91, 92). 
IDO has an immunoregulatory function in some situations, 
such as pregnancy, chronic infections, and tumors, by inhibit-
ing T cell proliferation, increasing T cell apoptosis, and altering 
the balance of Th1 and Th2 cells (93, 94). The effect of IDO on 
immune responses may largely depend on availability of its sub-
strate tryptophan and breakdown products of tryptophan (i.e., 
kynurenines). Kynurenine enhances the generation of regula-
tory T cells (Treg) through its interaction with aryl hydrocarbon 
receptors (95–97) (Figure 4). Kynurenine also promotes apop-
tosis of human and mouse neutrophils, and inhibits production 
of ROS (82) (Figure 4). Thus, a pathogen, such as Clostridium 
difficile, promotes activation of IDO to deplete the tryptophan 
pool of the host and diminish the immune responses of the host 
against the pathogen (Figure 4). A C. difficile infection induces 
the expression of IDO1 (4.7-fold) and production of kynurenine 
(about eightfold) in mouse intestinal lamina propria (82), while 
inhibition of tryptophan catabolism in IDO1-knockout mice 
increases the percentage of IFN-γ-expressing neutrophils and 
clearance of C. difficile from mice (82). Mycobacterium avium 
subsp. paratuberculosis infection promotes the expression of 
IDO in human monocytes in the gut and draining lymph nodes 
of sheep, and in peripheral blood cells of sheep and cattle, coin-
cident with a decrease in amounts of tryptophan in those cells 
(83). HIV infection is associated with increased tryptophan 
catabolism (i.e., a high ratio of kynurenine to tryptophan in 
plasma and IDO1 activation), expansion of Tregs, and depletion 
of Tc17/mucosa-associated invariant T  cells, while combina-
tion antiretroviral therapy in HIV-infected patients decreases 
tryptophan catabolism (98) (Figure  4). Further experiments 
demonstrated that HIV-induced IDO1 activation may be 
responsible for acute and progressive numeric loss of CD4+ 
T-helper cells and functional impairment of T-cell responses 
during an HIV infection (99). Mechanistically, the N-terminal 
domain of the HIV-1 transactivator regulatory protein (Tat) 
induces the initial expression of IDO, while increased IFN-γ 
FiGURe 4 | Tryptophan competition between host and Clostridium difficile or HIV. Upon C. difficile infection, tryptophan supports optimal effector T cell responses 
against C. difficile. C. difficile promotes activation of indoleamine 2,3-dioxygenase (IDO) via an unknown mechanism to convert tryptophan to kynurenine to deplete 
the tryptophan pool and diminish responses of effector T cells in the host. Kynurenine also promotes apoptosis of neutrophils, inhibits the production of reactive 
oxygen species from neutrophils, and enhances the generation of regulatory T cells (Treg) through the aryl hydrocarbon receptor (AhR). HIV induces expression  
of IDO through transactivator regulatory protein (Tat) and IFN-γ, leading to tryptophan catabolism, expansion of Tregs, loss of CD4+ T-helper cells, and functional 
impairment of T-cell responses.
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during HIV-1 infection enhances the expression of IDO in 
monocyte-derived dendritic cells (DC) (100) (Figure 4).
Tryptophan is also essential for the growth of some pathogens, 
thus IDO has an antimicrobial activity by depleting cells of tryp-
tophan. IDO is an anti-hepatitis B virus (HBV) effector based 
on evidence that patients with acute hepatitis B, but not hepatic 
flare, have robust activation of IDO (101). Further, patients with 
acute hepatitis who eventually clear HBV have increased IDO 
activity at the time of peak alanine aminotransferase activity, 
but patients with a hepatic flare-up have less IDO activity (101). 
Indeed, IDO promotes HBV suppression in Huh7 cells that is 
abrogated in IDO-knockout cells, but restored by re-induction 
of IDO in the cells (101). Inhibition of IDO in mice increases 
mortality and parasite burdens during Toxoplasma gondii 
infections (102). Depletion of tryptophan by high IDO activity 
causes Chlamydia trachomatis to lose infectivity and decrease 
transcriptional activity, but these outcomes are reversed in 
response to replenishment of cellular tryptophan pools (103). 
The suppression of IDO in the replication of intracellular patho-
gens also occurs in response to other pathogens, such as HIV 
(104), herpes simplex virus (105), and Chlamydia pneumonia 
(106). In parallel, some pathogens have evolved to synthesize 
tryptophan to protect them from local tryptophan depletion due 
to the increased expression of IDO during infection. M. avium 
subsp. paratuberculosis has the ability for tryptophan biosyn-
thesis because it expresses genes for trpA (tryptophan synthase 
subunit alpha, MAP1307), trpB (tryptophan synthase subunit 
beta, MAP1306), trpC (indole-3-glycerol-phosphate synthase, 
MAP1305), hisA (phos phoribosyl isomerase A, MAP1297), trpD 
(anthranilate phosphoribosyltransferase, MAP1931c), and trpE 
(anthranilate synthase component I, MAP1303), which are all 
involved in the biosynthesis of l-tryptophan (83).
Collectively, tryptophan is required for both host and patho-
gen and IDO has biologically important roles in the interaction 
between host and pathogen, especially intracellular pathogens. 
IDO not only dampens protective mechanisms for host immunity 
to increase pathogen burdens but also suppresses replication of 
pathogens to limit the spread of infection. Thus, the dominant 
nature of IDO (i.e., antimicrobial or immunoregulatory) is 
pathogen-specific.
Other AA
Our understanding of other AA involved in metabolic cross talk 
between host and pathogen lags far behind our understanding 
of the roles for arginine, asparagine, and tryptophan. There are 
sporadic reports on metabolism and regulation of other AA dur-
ing infection. For example, human cytomegalovirus (HCMV) 
infection causes host cells to use glutamine to produce the 
tricarboxylic acid cycle intermediate-alpha ketoglutarate due 
to the removal of citrate from the citric acid cycle to increase 
fatty acid biosynthesis (107, 108). Thus, infection may induce 
changes in the energy substrate from glucose to glutamine, 
which is the major source of ATP in HCMV infected human 
fibroblasts, but not in uninfected cells (107). Glutamine depri-
vation inhibits the formation of infectious virions, while alpha 
ketoglutarate supplementation rescues ATP production and 
viral growth under conditions of glutamine deprivation (107). 
Also, glutamine uptake by the sodium-dependent neutral amino 
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acid transporter 2 is required for motility and migration of T. 
gondii infected DCs (109).
Glutamate has a central role for bacteria due to its involvement 
in a wide range of metabolic processes. The glutamate-dependent 
acid resistance (GDAR) system is one of the best-characterized 
systems in commensal and pathogenic bacteria, including E. coli, 
Shigella flexneri, L. monocytogenes, and Lactococcus lactis (110). 
GDAR couples the glutamate decarboxylase(s) GadA and/or 
GadB, and glutamate:γ-amin obutyrate exchanger GadC (110). 
GadC has important roles for intracellular multiplication and 
virulence of Francisella because the ΔgadC mutant F. novicida 
exhibits impaired multiplication in macrophages, as well as in 
liver and spleen of mice (111). The ΔgadC mutant F. novicida is 
more sensitive to oxidative stress than the wild-type strain, but 
similar sensitivities to oxidative stress in a glutamate deficient 
medium (111). Further, ΔgadC mutant F. novicida loses the 
capacity to escape from the phagosomal compartment of infected 
macrophages due to a defect in its ability to neutralize ROS pro-
duced in the phagosomal compartment (111).
Thus, AA other than arginine, asparagine, and tryptophan can 
mediate interactions between a host and pathogen, and influence 
the outcome of the infection.
MODULATiON OF AA DURiNG AN 
iNFeCTiON
Amino acids are associated with interactions between a host and 
its pathogens and profoundly influence the outcome of infection. 
Therefore, AA therapy can be used to manipulate the pro gression 
of an infection. For example, a decrease in asparagine blocks GAS 
growth in human blood and GAS proliferation in a mouse model 
of human bacteremia (31). Glutamine deprivation inhibits for-
mation of infectious virions of HCMV (107). In PCV2 infected 
mice with a reproductive defect, dietary supplementation with 
functional AA (e.g., arginine, glutamine, and proline) enhances 
host defense responses that reduce replication of PCV2 and 
improve reproductive performance (112–114). In P. multocida-
infected animal models, dietary supplementation with arginine, 
glutamine, and proline promotes immune responses and 
decreases bacterial replication and their expression of virulence 
factors, as well as mortality (115–117). Collectively, AA influ-
ence the outcome of an infection by modulating the activation 
of host defensive responses and the growth of the pathogen or 
its expression of virulence factors. However, such knowledge 
should be transferred carefully in its application as a prophy-
lactic measurement against pathogens. It is difficult to inhibit 
growth of a pathogen by deprivation of AA without inhibiting 
the immune responses of the host and it seems impossible to 
improve the immune responses of the host through replenish-
ing of AA without promoting the growth of the pathogen. Thus 
whether adding or depleting one particular AA to favor the host 
to clear a pathogen depends on the specific metabolic situa-
tion associated with the pathogenic infection. Probiotics offer 
a promising surrogate to regulate the AA status of hosts. For 
example, the use of multi-species probiotics (Bifidobacterium 
bifidum W23, Bifidobacterium lactis W51, Enterococcus faecium 
W54, Lactobacillus acidophilus W22, Lactobacillus brevis W63, 
and Lactococcus lactis W58) can increase concentrations of tryp-
tophan in serum and reduce the incidence of upper respiratory 
tract infections in individuals (118). L. lactis-derived GABA also 
modifies the expression of IL-17 in the intestine during ETEC 
infection (51). It would be of great interest to use genetically 
engineered probiotics to compete with pathogens in acquiring 
essential AA.
CONCLUSiON
There is an obligatory and extensive metabolic cross talk between 
host and pathogens. Upon infection, the host alters metabolism 
to support defensive responses against the pathogen, while the 
pathogen uses metabolic cues to sense its anatomical position 
and the immune status of the host (17). The host has the abil-
ity to alter AA metabolism after an infection by a pathogen 
(9, 52). Thus, AA influence immune responses of the host 
against a pathogen, such as the function of innate immune cells 
(e.g., macrophage), the activation and differentiation of T cells 
and the production of antibodies by B  cells (27, 51, 112, 115, 
116, 119). Also, AA play an important role in the physiology 
and virulence of pathogens. Thus, a change in AA metabolism at 
the site of infection will influence the outcome of an infection. 
Some AA, such as arginine, asparagine, and tryptophan, are 
central to competition between host and pathogen. However, the 
importance of other AA, such as glutamine, proline, and GABA, 
in the metabolic cross talk between a host and pathogen, must 
be explored further. For example, there is a significant change 
in GABA signaling during ETEC infection that affects the 
expression of IL-17 in the intestine during ETEC infection (51). 
Also, strategies and mechanisms used by pathogens to compete 
with the host for AA remain to be discovered (see Table  1). 
Understanding metabolic cross talk involving AA between host 
and pathogen will offer significant insight into pathogenic infec-
tions and reveal novel treatments to prevent and cure infections 
by modulating the abundance of AA and/or the metabolism of 
those AA.
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